fluticasone propionate
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 12
Of
12
Go to page
1
September 04, 2025
Diagnosis and treatment of a patient with severe hepatitis and rash caused by toripalimab: A case report.
(PubMed, Medicine (Baltimore))
- "This case proposes that clinician should comprehensively determine the risk of adverse reactions and strengthen medication monitoring to ensure patient safety."
Journal • Hepatology • Inflammation • Liver Failure • Nasopharyngeal Carcinoma • Oncology • Solid Tumor
June 30, 2025
Seal, Stopping Eczema and Allergy Study
(clinicaltrials.gov)
- P2 | N=398 | Active, not recruiting | Sponsor: Kari Nadeau, MD, PhD | Recruiting ➔ Active, not recruiting
Enrollment closed • Allergy • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
April 22, 2025
Seal, Stopping Eczema and Allergy Study
(clinicaltrials.gov)
- P2 | N=312 | Recruiting | Sponsor: Kari Nadeau, MD, PhD | Trial completion date: Jun 2027 ➔ Jun 2028 | Trial primary completion date: May 2027 ➔ May 2028
Trial completion date • Trial primary completion date • Allergy • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
April 03, 2025
Q1 and Q2 Selection, Q3, IVRT, IVPT, pharmacokinetic and pharmacodynamic evaluation fo Topical Generic Product.
(PubMed, Drug Dev Ind Pharm)
- "A crucial study has exhibited that reference and test formulations are bioequivalent with a 90% confidence interval and results in 84.67%∼101.09%. The Cutivate® cream 0.05%, and proposed generic product Fluticasone Propionate cream 0.05% formulations are bioequivalent and have a favorable safety profile."
Journal • PK/PD data
February 11, 2025
Two Cases of Acquired Reactive Perforating Collagenosis in Hemodialysis Patients.
(PubMed, Semin Dial)
- "Two patients were treated with oral thalidomide and ebastine, local application of fluticasone propionate cream, and enhanced dialysis. We report for the first time that ARPC in patients with hemodialysis could be improved by oral thalidomide and antihistamines and local application of steroid. This report provides reference for guiding the understanding of ARPC and the new treatment of ARPC in hemodialysis patients."
Journal • Cardiovascular • Chronic Kidney Disease • Dermatology • Diabetes • Endocrine Disorders • Hypertension • Metabolic Disorders • Renal Disease • Type 2 Diabetes Mellitus
November 10, 2024
Comparative study on pharmacokinetics of fluticasone propionate cream in humans
(ChiCTR)
- P1 | N=12 | Not yet recruiting | Sponsor: Huzhou Central Hospital; Zhejiang Xianju Pharmaceutical Co., Ltd.
New P1 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
May 10, 2024
Seal, Stopping Eczema and Allergy Study
(clinicaltrials.gov)
- P2 | N=312 | Recruiting | Sponsor: Kari Nadeau, MD, PhD | Phase classification: P3 ➔ P2 | N=750 ➔ 312
Enrollment change • Phase classification • Allergy • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
May 07, 2024
Seal, Stopping Eczema and Allergy Study
(clinicaltrials.gov)
- P3 | N=750 | Recruiting | Sponsor: Kari Nadeau | Phase classification: P2 ➔ P3 | Trial primary completion date: Jul 2026 ➔ May 2027
Phase classification • Trial primary completion date • Allergy • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
July 08, 2021
Seal, Stopping Eczema and Allergy Study
(clinicaltrials.gov)
- P2; N=875; Recruiting; Sponsor: Kari Christine Nadeau, MD, PhD; Not yet recruiting ➔ Recruiting
Enrollment open • Allergy • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
May 21, 2021
Seal, Stopping Eczema and Allergy Study
(clinicaltrials.gov)
- P2; N=875; Not yet recruiting; Sponsor: Kari Christine Nadeau, MD, PhD; Phase classification: P1/2 ➔ P2
Phase classification • Allergy • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
February 16, 2021
Fluticasone propionate-loaded solid lipid nanoparticles with augmented anti-inflammatory activity: Optimization, characterization and pharmacodynamic evaluation on rats.
(PubMed, J Microencapsul)
- "The optimized FP-loaded SLNs maximized the efficacy of FP toward inflammation alleviation that increase its potential as efficient implement in inflammatory skin diseases remediation."
Journal • PK/PD data • Dermatology • Immunology • Inflammation • TNFA
June 23, 2020
Drugs for atopic dermatitis.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
1 to 12
Of
12
Go to page
1